SHENZHEN, China, May 22, 2015 /PRNewswire/ -- China Nepstar
Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"),
a leading retail drugstore chain in China based on the number of directly operated
stores, today announced the resignation of Mr. Fuxiang Zhang as the Company's Chief Executive
Officer for personal reasons, effective immediately. Ms.
Rebecca Yingnan Zhang has been
appointed as Chief Executive Officer by the Company's board of
directors, effective immediately. Meanwhile, Ms. Zhang resigned
from the position as Chief Operating Officer, effective
immediately.
The Company also announced the appointment of Ms. Rebecca Yingnan Zhang as a director of the
Company, effective immediately.
Ms. Zhang has over 20 years of experience in the pharmaceutical
industry. She joined Nepstar in March
1999 and has been with the Company ever since. In
November 2014, Ms. Zhang was
appointed as Chief Operating Officer of the Company. Prior to that,
she served as executive vice president in charge of procurement,
merchandising, logistics and quality departments starting from
April 2014. She was the Company's
vice president of procurement and merchandising from January 2009 to April
2014 and served as head of procurement department prior to
that. Ms. Zhang received a bachelor's degree in microbiological
pharmaceuticals in 1991 from
Shenyang Pharmaceutical University.
Mr. Simin Zhang, Chairman of the
Company, commented, "On behalf of the board of directors, we thank
Fuxiang for his many years of contribution to our growth. We remain
confident in the growth prospect of Nepstar and look forward to a
new stage of our business under the leadership of Rebecca. We
believe that she will be an indispensable asset of the Company in
her new roles."
About China Nepstar Chain Drugstore Ltd.
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is a leading
retail drugstore chain in China. As of March 31, 2015,
the Company had 1,969 directly operated stores across 74 cities,
one headquarter distribution center and 15 regional distribution
centers in China. Nepstar uses directly operated stores,
centralized procurement and a network of distribution centers to
provide its customers with high-quality, professional and
convenient pharmaceutical products and services and a wide variety
of other merchandise, including OTC drugs, nutritional supplements,
herbal products, personal care products, family care products, and
convenience products. Nepstar's strategy of centralized
procurement, competitive pricing, customer loyalty programs and
private label offerings has enabled it to capitalize on the
continuing economic growth in China and take advantage of the
demographic trend in China to achieve a strong brand and
leading market position. For further information, please go
to http://www.nepstar.cn.
Safe Harbor Statement
This press release contains forward-looking statements. These
statements constitute "forward-looking" statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be
identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates" and similar
statements. Among other things, the quotations from management in
this press release and the Company's strategic operational plans
and business outlook, contain forward-looking statements. Such
statements involve certain risks and uncertainties that could cause
actual results to differ materially from those in the
forward-looking statements. Further information regarding these and
other risks is included in the Company's filings with the U.S.
Securities and Exchange Commission, including its annual report on
Form 20-F. The Company does not undertake any obligation to update
any forward-looking statement as a result of new information,
future events or otherwise, except as required under applicable
law.
Contacts
Zixin Shao
China Nepstar Chain Drugstore Ltd.
Chief Financial Officer
+86-755-2641-4065
ir@nepstar.cn
Shiwei Yin
Grayling
Investor Relations
+1-646-284-9474
npd@grayling.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/china-nepstar-chain-drugstore-ltd-announces-management-change-and-new-director-appointment-300087774.html
SOURCE China Nepstar Chain Drugstore Ltd.